Abstract
The aim of this article is to study the prevalence, clinicolaboratory features, WHO histological types, therapy and renal outcome of lupus nephritis (LN) in Saudi Arabia. During the 27-year-period (1980–2006), 299 (47.9%) cases of LN were identified among the 624 cases of systemic lupus erythematosus (SLE) follow-up at King Khalid University Hospital, Riyadh. The female:male ratio in LN was 8.3:1, with a mean age of 32 years and a mean age of onset of 23 years. The WHO renal histological types were; Class I (1%), Class II (18.1%), Class III (10%), Class IV (37.1%), Class V (11.7%), and Class VI (2.7%). Azathioprine was given to 43.1% and pulse cyclophosphamide to 65.6% in combination with other drugs. Remission was seen in 226 (75.6%) patients, renal flares in 14 (4.7%), end stage renal disease (ESRD) in 27 (9.0%), death in 18 (6.0%), and 14 (4.7%) lost follow-up. The 5- and 10-year patient survival rates in our whole LN cohort by Kaplan–Meier analysis were 96% and 95%, respectively. The survival did not differ significantly in different LN classes nor did it differ significantly during the three periods of presentation (1980–1990, 1991–2000, and 2001–2006; P > 0.05). The risk factors for poor survival were found to be older age at onset (>50-years age; P = 0.034), ESRD (P = 0.000), and low C3 (P = 0.022). The risk factors for progression to ESRD were older age at onset (>50-years age; P = 0.037), hypertension (P = 0.009), elevated serum creatinine (P = 0.000), and proliferative LN (Classes III, IV; P = 0.013, P = 0.039). Different treatment modalities did not have significant effect on survival in the whole LN cohort (P = >0.05). However, pulse cyclophosphamide favored remission in Classes II, III, IV, and V (P = 0.023). The main causes of death were renal failure (50%) and infections (44.4%).
Similar content being viewed by others
References
Tsao BP (1998) Genetic susceptibility to lupus nephritis. Lupus 7:585–590. doi:10.1191/096120398678920695
Golbus J, McCune WJ (1994) Lupus nephritis: classification, prognosis, immunopathogenesis, and treatment. Rheum Dis Clin North Am 20:213–242
Schwartz MM (1995) Lupus nephritis. Curr Opin Nephrol Hypertens 4:162–168. doi:10.1097/00041552-199503000-00009
Mok CC (2005) Prognostic factors in lupus nephritis. Lupus 14:39–44. doi:10.1191/0961203305lu2057oa
Mavragani CP, Moutsopoulos HM (2003) Lupus nephritis: current issues. Ann Rheum Dis 62:795–798. doi:10.1136/ard.62.9.795
Mojcik CF, Klippel JH (1996) End-stage renal disease and systemic lupus erythematosus. Am J Med 101:100–107. doi:10.1016/S0002-9343(96)00074-5
Ponticelli C (1997) Treatment of lupus nephritis—the advantages of a flexible approach. Nephrol Dial Transplant 12:2057–2059. doi:10.1093/ndt/12.10.2057
Churg J, Sobin LH (1982) Renal disease: classification and atlas of glomerular disease. Igaku-Shoin, Tokyo, pp 127–149
Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE (1995) High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 10:1620–1628
Nosset JC (1992) Systemic lupus erythematosus on the Caribbean Island of Curacao: an epidemiological investigation. Ann Rheum Dis 51:1197–1201
Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN (1997) Occasional series: lupus around the world. Systemic lupus erythematosus in India. Lupus 6:690–700. doi:10.1177/096120339700600903
Wong KL (1992) Pattern of SLE in Hong Kong Chinese: a cohort study. Scand J Rheumatol 21:289–296. doi:10.3109/03009749209099244
Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 72:113–124. doi:10.1097/00005792-199303000-00005
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277. doi:10.1002/art.1780251101
Chahade WH, Sato E, Moura JE Jr, Costallat LT, Andrade LE (1995) Systemic lupus erythematosus in Sao Paulo/Brazil: a clinical and laboratory overview. Lupus 4(2):100–103. doi:10.1177/096120339500400204
Al Attia HM (1996) Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J 72:677–679
Rabbani MA, Tahir MH, Siddiqui BK et al (2005) Renal involvement in systemic lupus erythematosus in Pakistan. JPMA 55:328–332
Huong DLT, Papo T, Beaufils H et al (1999) Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine 78(3):148–166. doi:10.1097/00005792-199905000-00002
Al Jarallah K, Al Awadi A, Siddiqui H et al (1998) Occasional series: lupus around the world. Systemic lupus erythematosus in Kuwait—hospital based study. Lupus 7:434–438. doi:10.1191/096120398678920389
Levy Y, George J, Hojnic M et al (1996) Comparison of clinical and laboratory parameters for systemic lupus erythematosus activity in Israelis versus Europeans. Isr J Med Sci 32:100–104
Hochberg MC, Boyd RE, Ahearn JM et al (1985) Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 64(5):285–295. doi:10.1097/00005792-198509000-00001
Al Balla SR (1995) Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 14(3):342–346. doi:10.1007/BF02208351
Qari FA (2002) Clinical pattern of systemic lupus erythematosus in Western Saudi Arabia. Saudi Med J 23(10):1247–1250
Al Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M (2007) Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus 16(9):755–763. doi:10.1177/0961203307079943
Heller T, Ahmed M, Siddiqi A, Wallrauch C, Bahlas S (2007) Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population. Lupus 16(11):908–914. doi:10.1177/0961203307081112
Hayslett JP, Kashgarian M (1993) Nephropathy of systemic lupus erythematosus. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney, 5th edn. Little Brown and Company, Boston, pp 2019–2037
Martins L, Rocha G, Rodrigues A et al (2002) Lupus nephritis: a retrospective review of 78 cases from a single centre. Clin Nephrol 57(2):114–119
Isenberg DA (1993) Immunological tests in autoimmune rheumatic disease. Br J Hosp Med 50:215–220
Uthman IW, Muffarij AA, Mudawar WA, Nasr FW, Masri AFM (2001) Occasional series: lupus around the world. Lupus nephritis in Lebanon. Lupus 10:378–381. doi:10.1191/096120301670808045
Shayakul C, Ong-aj-yooth L, Chirawong P et al (1995) Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis 26(2):300–307
Neuman K, Wallace DJ, Azen C et al (1995) Lupus in the 1980s. III. Influence of clinical variables, biopsy and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 25:47–55. doi:10.1016/S0049-0172(95)80017-4
Derksen RH, Hene RJ, Kater L (1992) The long term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed by a single center. Lupus 1(2):97–103. doi:10.1177/096120339200100207
Seedat YK, Parag KB, Ramsaroop R (1994) Systemic lupus erythematosus and renal involvement. A South African experience. Nephron 66(4):426–430
Bono L, Cameron JS, Hicks JA (1999) The very long-term prognosis and complications of lupus nephritis and treatment. Q J Med 92:211–218
Brugos B, Kiss E, Szodoray P, Szegedi G, Zeher M (2006) Retrospective analysis of patients with lupus nephritis: data from a large clinical and immunological center in Hungary. Scand J Immunol 64:433–437. doi:10.1111/j.1365-3083.2006.01833.x
Al Attia HM, Al Ahmed YH, Chandani AU (1998) Serological markers in Arabs with lupus nephritis. Lupus 7:198–201. doi:10.1191/096120398678920569
Mitwalli AH, Al Wakeel JS, Al Mohaya SS, Malik HG, Abu-Aisha H, Hassan OS et al (1996) Pattern of glomerular disease in Saudi Arabia. Am J Kidney Dis 27(6):797–802. doi:10.1016/S0272-6386(96)90516-8
Akhtar M, Qunibi W, Taher S et al (1990) Spectrum of renal disease in Saudi Arabia. Ann Saudi Med 10(1):37–44
Al Zahrani IH, Qayyum A (2007) Lupus nephritis. Clinicopathological correlation. Saudi Med J 28(10):1503–1505
Mok CC, Wong RWS, Lau CS (1999) Lupus nephritis in southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 34:315–323. doi:10.1016/S0272-6386(99)70361-6
Wang LC, Yang YC, Lu MY, Chiang BL (2003) Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect 36:203–208
Donadio JV Jr, Hart GM, Bergstralh EJ, Holley KE (1995) Prognostic determinants in lupus nephritis: a long term clinicopathologic study. Lupus 4:109–115
Yang LY, Chen WP, Lin CY (1994) Lupus nephritis in children. A review of 167 patients. Pediatrics 94:335–340
Wang LC, Yang YH, Lu MY, Chiang BL (2004) Retrospective analysis of the renal outcome in pediatric lupus nephritis. Clin Rheumatol 23:318–323. doi:10.1007/s10067-004-0919-2
Appel GB, D’ Agati V (1994) Renal involvement in multisystem disease. Part 1: lupus nephritis. In: Massry SG, Glassock R (eds) Textbook of nephrology. Lippincott Williams and Wilkins, Philadelphia, pp 787–796
Fiehn C, Hajjar Y, Mueller K, Waldherr R, Ho AD, Andrassy K (2003) Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 62:435–439. doi:10.1136/ard.62.5.435
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Al Arfaj, A.S., Khalil, N. & Al Saleh, S. Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia. Rheumatol Int 29, 1057–1067 (2009). https://doi.org/10.1007/s00296-009-0905-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0905-8